S 483 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill would stop companies from advertising new drugs directly to regular people — including on social media — for the first three years after the drug is approved by the FDA. However, a drug company can ask the FDA for permission to start advertising during the third year if the FDA decides the ads would be good for public health. The FDA could also keep the advertising ban going past three years if studies or reports show the drug causes serious health problems. This rule would apply to new drugs approved starting one year before the bill becomes law.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.